v3.23.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Operating costs and expenses:    
Research and development $ 1,047 $ 836
Selling, general and administrative 4,281 4,100
Total operating costs and expenses 5,328 4,936
Loss from operations (5,328) (4,936)
Other income:    
Interest expense (119) (390)
Interest income and other income, net 5,511 38
Non-cash interest income on liability related to sale of future royalties 0 673
Total other income 5,392 321
Net income (loss) from continuing operations 64 (4,615)
Net loss from discontinued operations– See Note 3 (8,216) (4,059)
Net loss $ (8,152) $ (8,674)
Basic and diluted, continuing operations (in dollars per share) $ 0.00 $ (0.63)
Basic and diluted, discontinued operations (in dollars per share) (0.75) (0.56)
Basic and diluted loss per share (in dollars per share) $ (0.75) $ (1.19)
Shares used in computing net loss per share of common stock, basic and diluted – See Note 10 (in shares) 10,893,954 7,281,187